GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Vericel Corporation
Vericel is a biotech company specializing in cell therapy for cartilage and skin restoration. Its stock price is driven by the number of surgical procedures performed using its products to treat sports injuries and burns.
Share prices of companies in the market segment - Pharma skin
Vericel is a biotech company specializing in cell therapy for cartilage and skin restoration. We classify it as a Pharma Skin company, and the chart below shows the overall segment's performance, as well as the sales history of its products for the treatment of sports injuries and burns.
Broad Market Index - GURU.Markets
Vericel is a biotech company that develops and markets cell-based therapies for knee cartilage restoration and the treatment of severe burns. It is a component of the GURU.Markets index. The chart below represents the market. See how Vericel shares compare to the biotech sector.
Change in the price of a company, segment, and market as a whole per day
VCEL - Daily change in the company's share price Vericel Corporation
Shares of Vericel, a cell therapy company, exhibit high volatility, as measured by change_co. This reflects sensitivity to product sales and research results. This metric is important for analyzing the innovative biotech sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma skin
Vericel Corporation is a biotech company. This chart highlights the sector's high volatility. Comparing it to VCEL, which focuses on cell therapy for cartilage and skin restoration, helps understand its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Vericel is a biopharmaceutical company specializing in cell therapy for cartilage and skin restoration. The biotech sector is extremely volatile, and Vericel's story is a prime example. The chart below reflects the industry's average price movements, providing context for Vericel's stock valuation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Vericel Corporation
Vericel is a biotech company specializing in cell therapies for skin and cartilage restoration. Its year-over-year performance reflects the commercial success of its drugs and investor confidence in its R&D platform.
Annual dynamics of market capitalization of the market segment - Pharma skin
Vericel Corporation is a commercial biotechnology company specializing in cell therapies for cartilage and skin restoration. Its unique products are used to treat sports injuries and burns. The chart below shows how its innovative niche and the growing adoption of its technologies influence its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vericel, with its cell therapy technologies for skin and cartilage restoration, is a growth story in medicine. Its stock price is determined not by the economy, but by the speed of adoption of its treatments by doctors and the insurance system. The chart reflects the potential of this breakthrough technology in regenerative medicine.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Vericel Corporation
Vericel, a biotech company specializing in cell therapy for cartilage and skin restoration, shows monthly fluctuations in the graph, reflecting the number of procedures performed using its unique products, which are driven by elective orthopedic and burn surgeries.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Vericel Corporation develops and markets cell therapies for the restoration of damaged tissue, such as knee cartilage or burn-related skin. This is cutting-edge regenerative medicine. The graph below shows the dynamics of the biotech sector, where cell technologies are one of the most promising areas.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vericel Corporation is a leader in advanced cell therapies for the restoration of damaged tissues, including cartilage and skin. Its business depends on the number of surgical procedures and the adoption of its technologies. The broader market graph serves as a backdrop to assess how its unique, FDA-approved regenerative medicine products have enabled its growth trajectory.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Vericel Corporation
Shares of Vericel Corporation, a company developing cell therapy for skin and cartilage restoration, reflect progress in regenerative medicine on a weekly basis. Price movements reflect the number of procedures using their products and the expansion of their surgical applications.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Regenerative medicine is a sector where weekly performance reflects advances in cellular technologies. Demand for burn treatment and cartilage restoration is a common driver. The chart illustrates this backdrop, which allows for the evaluation of Vericel's innovative products.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Vericel develops cell therapies for cartilage and skin restoration. The company is at the forefront of regenerative medicine. The chart will show whether Vericel shares are living their own life, responding to scientific breakthroughs and regulatory approvals, or whether general market volatility is driving their weekly performance.
Market capitalization of the company, segment and market as a whole
VCEL - Market capitalization of the company Vericel Corporation
Vericel's market capitalization tells the story of a pioneer in cell therapy for cartilage and skin restoration. Its chart reflects the slow but steady growth of surgeon acceptance of its unique products. Its growth reflects the market's assessment of its ability to expand the use of regenerative medicine and make it a standard of care.
VCEL - Share of the company's market capitalization Vericel Corporation within the market segment - Pharma skin
Vericel Corporation occupies a unique niche in regenerative medicine, offering cell therapy for knee cartilage restoration and the treatment of severe burns. Its dominant share in these markets reflects the uniqueness of its products. The chart shows the weight of this pioneer, whose technologies literally help grow new tissue.
Market capitalization of the market segment - Pharma skin
Vericel is a company specializing in cell therapy for the restoration of damaged tissues such as cartilage and skin. The chart below shows the biotech sector's market capitalization. Its dynamics reflect the disruptive nature of regenerative medicine, in which Vericel is one of the few commercially successful players.
Market capitalization of all companies included in a broad market index - GURU.Markets
Vericel produces cell therapies for knee cartilage restoration and the treatment of severe burns. Its market capitalization is based on its unique regenerative technologies. The chart below shows the economic weight of the regenerative medicine and cell therapy sector.
Book value capitalization of the company, segment and market as a whole
VCEL - Book value capitalization of the company Vericel Corporation
Vericel's book value stems from its unique cell therapy production facilities, where patients' own cells are grown to treat burns and cartilage damage. This is tangible, biotechnological capital, the foundation of regenerative medicine. How has this innovative asset grown? The chart below shows its dynamics.
VCEL - Share of the company's book capitalization Vericel Corporation within the market segment - Pharma skin
Vericel produces cell therapy products, including cartilage and skin growth for patients, in its unique laboratories. The chart shows the share of these cutting-edge biotech assets, reflecting the physical foundation on which regenerative medicine is built.
Market segment balance sheet capitalization - Pharma skin
Regenerative medicine, as the BCap_Seg chart for biotech shows, is highly technological. Vericel Corporation, which grows patient-derived cells to treat burns and cartilage damage, requires unique and certified manufacturing laboratories, making its business capital-intensive in its niche.
Book value of all companies included in the broad market index - GURU.Markets
Vericel Corporation's assets are unique biotech manufacturing facilities where patients' own cells are grown for regenerative medicine. The book value reflects the physical capital invested in creating "living tissue factories" for the treatment of burns and cartilage damage.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Vericel Corporation
Vericel develops cell therapies for skin and cartilage restoration. Its book value doesn't reflect the value of its unique, FDA-approved products. The MvsBCap chart shows the high premium the market is paying for its biotechnology. Its growth will depend on the growing number of doctors using its therapies and the expansion of their indications.
Market to book capitalization ratio in a market segment - Pharma skin
Vericel Corporation develops cell therapies for the treatment of burns and cartilage damage. As a biotech company, its value lies in its unique technologies and approved products. The chart shows the premium the market pays for its innovative regenerative medicine methods.
Market to book capitalization ratio for the market as a whole
Vericel Corporation develops cell therapies for the restoration of damaged tissues, such as cartilage and skin. This is a cutting-edge field of medicine. The company's market valuation reflects the uniqueness of its technologies and growth potential, not the value of its laboratories. The chart shows the premium investors are paying for regenerative medicine.
Debts of the company, segment and market as a whole
VCEL - Company debts Vericel Corporation
Vericel, a biotech company specializing in cell therapy, is using capital to expand production and commercialize its approved products. Scaling up live cell production is a complex and expensive process. This chart shows how the company is investing to make its innovative treatments accessible to more patients.
Market segment debts - Pharma skin
Vericel Corporation develops and manufactures cell therapies for the restoration of damaged tissues, such as cartilage and skin. Biotechnology is a capital-intensive field, requiring significant investment to move from research to commercial production. The chart shows how Vericel funds its unique manufacturing processes and sales expansion.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Vericel Corporation
Vericel Corporation develops and manufactures cell therapies for the treatment of burns and cartilage damage. The chart shows how the company finances its unique production. For a biotech company with already commercialized products, debt can be a tool for expanding production capacity and marketing. Its level reflects the balance between growth and risk.
Market segment debt to market segment book capitalization - Pharma skin
Vericel Corporation develops cell therapies for skin and cartilage restoration. This business operates at the intersection of biotechnology and medicine. This metric for the pharmaceutical sector reflects how companies finance the commercialization of innovative but expensive treatments, allowing one to evaluate Vericel's financial strategy against this backdrop.
Debt to book value of all companies in the market
Vericel Corporation is a biotech company operating at the cutting edge of science. This chart reflects the overall risk appetite in the economy. For a company burning capital for future discoveries, it helps understand how its risky funding model compares to the overall market conditions and investors' willingness to wait.
P/E of the company, segment and market as a whole
P/E - Vericel Corporation
The chart for Vericel Corporation, a company developing cell therapy for cartilage and skin restoration, shows how investors value its unique regenerative technologies. The high values reflect expectations for widespread use of its products in sports medicine and burn treatment, promising significant growth potential.
P/E of the market segment - Pharma skin
This chart shows the average P/E ratio for the biotech sector, where Vericel offers cell therapies. The industry's high valuation reflects expectations for regenerative medicine. This metric provides context for assessing the market premium for Vericel's already commercialized and profitable products.
P/E of the market as a whole
Vericel Corporation develops and manufactures cell therapies for the treatment of severe burns and cartilage damage. The company is a pioneer in the field of regenerative medicine. This biotech sentiment chart helps understand how the market values Vericel's unique and patented products, which are already generating revenue and changing patients' lives.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Vericel Corporation
Vericel Corporation develops cell therapies to repair damaged tissue, such as knee cartilage or burn-related skin. The graph reflects future revenue expectations, which depend on the growing number of surgeons using its products and approval of new applications. This is a bet on regenerative medicine.
%20P%2FE%20Vericel%20Corporation&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Vericel-Corporation&v=1772686548885 "Chart of the company's future (projected) P/E Vericel Corporation")
Future (projected) P/E of the market segment - Pharma skin
Vericel Corporation develops and manufactures cell therapies for the restoration of damaged tissue, such as knee cartilage or burn-related skin. The chart shows average profitability expectations for the sector, helping to understand the extent to which investors believe in the commercial potential of this cutting-edge regenerative medicine and its widespread application.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772686548900 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Vericel Corporation develops and manufactures cell therapies for the treatment of severe burns and cartilage defects. It is a company at the forefront of regenerative medicine. This overall risk appetite chart shows how willing investors are to invest in innovative medical technologies with long commercialization cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772686548923 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Vericel Corporation
Vericel Corporation develops and manufactures cell therapies for the restoration of damaged tissue, such as knee cartilage or burn-related skin. Profits are based on the number of patients treated with its innovative products. This chart shows the financial results of the company, which is at the forefront of regenerative medicine.
Profit of companies in the market segment - Pharma skin
Vericel Corporation is a biotech company specializing in cell therapy for repairing damaged tissue, such as knee cartilage or burn-related skin. This is cutting-edge medicine. This chart reflects the overall profitability of the regenerative medicine sector, where unique technologies can create entirely new markets and treatment standards.
Overall market profit
Vericel Corporation develops cell therapies to restore damaged tissues, such as cartilage and skin. Demand for its innovative treatments is driven by medical needs and recognition from the medical community. This business is not dependent on economic cycles, as illustrated by this chart, as health is the top priority.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Vericel Corporation
Vericel Corporation develops and commercializes cell therapies for the treatment of severe burns and cartilage damage. Future revenue depends on the growth of treatments using its products and approvals for new applications. This chart shows analysts' assessments of the regenerative medicine landscape and Vericel's place within it.
%20profit%20of%20the%20company%20Vericel%20Corporation&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Vericel-Corporation&v=1772686549009 "Graph of future (projected) profit of the company Vericel Corporation")
Future (predicted) profit of companies in the market segment - Pharma skin
Vericel Corporation develops and manufactures cell therapies for the restoration of damaged tissue, such as knee cartilage or burn-related skin. The company is a pioneer in the field of regenerative medicine. This chart shows revenue projections for the biotech sector, providing context for evaluating Vericel's innovative products.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772686549063 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Vericel Corporation specializes in developing cell therapies for the treatment of severe burns and cartilage defects. Demand for its products depends on the number of procedures performed. This economic outlook chart is important because it reflects the financial stability of the healthcare system, which is essential for the implementation of advanced treatments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772686549097 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Vericel Corporation
Vericel Corporation develops cell therapies to repair damaged tissues, such as cartilage and skin. Revenue growth reflects the adoption of its innovative treatments. This chart shows the premium investors are paying for cutting-edge biotechnologies that have the potential to transform the standard of medical care.
P/S market segment - Pharma skin
Vericel Corporation is a leader in cell therapy for tissue repair. The company is commercializing two products for knee cartilage regeneration and for the treatment of severe burns using a patient's own cells. This chart reflects the average revenue estimate for the sector, helping to assess the potential of Vericel's advanced regenerative technologies.
P/S of the market as a whole
Vericel Corporation develops and manufactures cell therapies for the treatment of severe burns and cartilage defects. The company is a leader in regenerative medicine. This chart helps understand the premium investors are willing to pay for unique and patented medical technologies compared to average market revenue estimates.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Vericel Corporation
Vericel Corporation develops and manufactures cell therapies for the treatment of severe burns and cartilage defects. For a company operating in the field of regenerative medicine, future revenue estimates are crucial. They reflect investors' expectations for the growth of procedures using its unique products and the expansion of their use in medical practice for tissue repair.
%20P%2FS%20Vericel%20Corporation&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Vericel-Corporation&v=1772686549223 "The graph of the company's future (projected) P/S Vericel Corporation")
Future (projected) P/S of the market segment - Pharma skin
Vericel Corporation develops and manufactures cell therapies for the treatment of severe burns and cartilage restoration in the knee joint. This chart reflects how investors view the company's future revenues relative to the biotech sector. It demonstrates the market's confidence in its unique regenerative technologies and their potential for growth as their use in surgical practice expands.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772686549244 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Vericel Corporation develops cell therapies for the restoration of damaged tissues, such as cartilage or skin. This is cutting-edge medicine, and demand for it is expected to grow. In the context of the overall revenue projections shown in the chart, Vericel represents an innovative sector with enormous potential.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772686549291 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Vericel Corporation
For Vericel Corporation, this figure reflects revenue from sales of innovative cell therapy products for cartilage restoration (MACI) and severe burn treatment (Epicel). Revenue growth is directly related to the increasing number of surgeons using these advanced regenerative medicine techniques and expanded insurance coverage for such procedures.
Sales of companies in the market segment - Pharma skin
Vericel Corporation specializes in cell therapy for tissue repair. Its sales breakdown shows which of its two main products generates more revenue: MACI (for knee cartilage repair) or Epicel (for the treatment of severe burns). This reflects the demand for its innovative regenerative treatments.
Overall market sales
Vericel Corporation develops cell therapies for the restoration of damaged tissues, such as cartilage and skin. The company is at the forefront of regenerative medicine. Its success depends on the implementation of innovative treatments. This general economic graph does not reflect the specific growth of this sector, where technological breakthroughs are the primary driver.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Vericel Corporation
Vericel Corporation is a biotechnology company specializing in the development of cell therapies for the restoration of damaged tissue, such as cartilage and skin after burns. Revenue growth depends on increased use of its unique products by surgeons. This chart shows analyst sales forecasts, reflecting their assessment of the adoption of regenerative medicine.
%20sales%20of%20the%20company%20Vericel%20Corporation&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Vericel-Corporation&v=1772686549413 "Schedule of future (projected) sales of the company Vericel Corporation")
Future (projected) sales of companies in the market segment - Pharma skin
Vericel Corporation develops cell therapies to treat severe burns and cartilage damage. This chart shows sales forecasts for the biotech sector. Is the regenerative medicine market expected to grow thanks to breakthrough technologies? This helps assess the overall potential of this cutting-edge healthcare field.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772686549430 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Vericel Corporation develops and manufactures cell therapies for the treatment of burns and cartilage damage. Demand for its products is driven by medical needs and the decisions of physicians and hospitals, not by the state of the economy. This chart, reflecting consumer spending, is not directly related to Vericel's business, which is in a highly specialized medical niche.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772686549518 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Vericel Corporation
Vericel Corporation develops and markets cell therapies for the treatment of severe burns and the restoration of knee cartilage. This chart illustrates how profitable the regenerative medicine business can be. The company's profitability depends on the uniqueness of its products, which are grown from a patient's own cells, and the willingness of insurance companies to cover these expensive procedures.
Market segment marginality - Pharma skin
Vericel Corporation is a biotechnology company specializing in cell therapy for the restoration of damaged tissue, such as knee cartilage or burn-related skin. This metric reflects the financial performance of a company with unique, approved products whose profitability depends on increased use by surgeons and reimbursement from insurance companies.
Market marginality as a whole
Vericel Corporation develops cell therapy for the treatment of burns and cartilage damage. Demand for its innovative products depends on their acceptance by surgeons and insurance coverage. This overall profitability chart reflects the state of the healthcare system and its ability to implement advanced, yet expensive, treatments.
Employees in the company, segment and market as a whole
Number of employees in the company Vericel Corporation
Vericel Corporation develops and markets cell therapies for cartilage and skin restoration. Its staff includes specialists in highly complex manufacturing and a commercial team. This chart shows how the company is expanding its specialized manufacturing and commercial capabilities to meet demand for its innovative products.
Share of the company's employees Vericel Corporation within the market segment - Pharma skin
Vericel Corporation develops and manufactures cell therapies for the restoration of damaged tissue, such as knee cartilage or burn-related skin. Producing living cell products is a complex process that requires a team of scientists and technicians. This chart shows the company's market share in the biotech industry, reflecting its unique manufacturing expertise and scientific potential.
Number of employees in the market segment - Pharma skin
Vericel Corporation develops and manufactures cell therapies for the treatment of severe burns and cartilage defects. This chart shows its activities in the regenerative medicine and skin pharmaceuticals sectors. Vericel's unique products, which utilize a patient's own cells for tissue repair, place the company at the forefront of personalized medicine.
Number of employees in the market as a whole
Vericel Corporation develops cell therapies to restore damaged tissues, such as cartilage and skin. The growth of its team of scientists and technicians is an indicator of the development of regenerative medicine. Unlike overall employment, hiring at Vericel reflects scientific breakthroughs and the commercialization of cutting-edge biotechnologies rather than the economic cycle.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Vericel Corporation (VCEL)
Vericel Corporation develops cell therapies for tissue repair. This chart shows how the market values their unique regenerative technologies. The company's value stems from their patents and sophisticated manufacturing processes. Their high market capitalization per employee reflects the high margins and science-intensive nature of their unique products.
%20of%20the%20company%20Vericel%20Corporation%20(VCEL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Vericel-Corporation-VCEL&v=1772686549719 "Chart of market capitalization per employee (in thousands of dollars) of the company Vericel Corporation (VCEL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Vericel (VCEL) is a company specializing in cell therapy for sports medicine and burn treatment. They extract a patient's cells, grow them, and implant them back into the body (for example, MACI for cartilage). This chart shows the industry average cost per employee. It helps estimate the premium the market pays for their unique regenerative medicine technology.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772686549760 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Vericel Corporation develops and manufactures cell therapies for skin and cartilage restoration. This is at the forefront of biotechnology. The chart shows a high employee value, as the company offers unique, FDA-approved products. The market is assessing the value of this technology and its potential for growth in regenerative medicine.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772686549785 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Vericel Corporation (VCEL)
Vericel is a biotech company specializing in regenerative medicine, specifically burn treatment (skin regrowth) and cartilage restoration. The company has commercial products. This chart shows how effectively the team monetizes these unique, complex, and expensive medical procedures, generating revenue.
%20Chart%20Vericel%20Corporation%20(VCEL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Vericel-Corporation-VCEL&v=1772686549837 "Company Profit Per Employee (in thousands of dollars) Chart Vericel Corporation (VCEL)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Vericel (VCEL) is in "regenerative medicine" (cell therapy for burns and cartilage). This chart shows the benchmark for "Pharma" (Skin). The average profit per employee in this sector is high. It's an "R&D business." The benchmark reflects the high margins of patented, one-of-a-kind B2B procedures.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772686549865 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Vericel Corporation is a biotech company specializing in cell therapies for cartilage repair (MACI) and burn treatment (Epicel). It's a niche, profitable biotech business. This chart shows how their unique, labor-intensive (cell cultivation) products are in demand by surgeons and offer high margins.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772686549888 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Vericel Corporation (VCEL)
Vericel Corporation develops and manufactures cell therapies for the treatment of burns and cartilage damage. This chart shows how cutting-edge science translates into revenue. The high revenue per employee reflects the uniqueness and high cost of their products, which require complex manufacturing and expertise.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Vericel-Corporation-VCEL&v=1772686549902 "Sales chart per company employee Vericel Corporation (VCEL)")
Sales per employee in the market segment - Pharma skin
Vericel Corporation (VCEL) is a biotech company specializing in cell therapies for cartilage repair (MACI) and burn treatment (Epicel). These are complex, living products. This chart shows the average production in the sector. For VCEL, this is an indicator of how productive their highly specialized manufacturing and commercial teams are in selling these unique therapies.
Sales per employee for the market as a whole
Vericel is a biotech company specializing in cell therapy for skin (burns) and cartilage (knees) restoration. They grow the patient's own cells. This demonstrates the effectiveness of their complex, personalized manufacturing process and commercial team.
Short shares by company, segment and market as a whole
Shares shorted by company Vericel Corporation (VCEL)
Vericel (VCEL) specializes in cell therapy for knee cartilage repair (MACI) and severe burn treatment (Epicel). This chart shows the volume of bearish bets. The shorts may be due to doubts about the widespread adoption of these complex and expensive procedures or concerns about competing developments.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Vericel-Corporation-VCEL&v=1772686550014 "Short Shares Chart for the Company Vericel Corporation (VCEL)")
Shares shorted by market segment - Pharma skin
Vericel (VCEL) specializes in cell therapy for sports medicine and burn treatment, growing a patient's own cells to restore cartilage or skin. This chart summarizes short positions in the cell therapy sector. It reflects investor concerns about the complexity and high cost of these procedures, as well as reimbursement issues.
Shares shorted by the overall market
Vericel (VCEL) is a biotech company focused on cell therapy. This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and shed risk. Biotech stocks, even those with approved drugs, often suffer sell-offs when general pessimism rules the market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Vericel Corporation (VCEL)
Vericel (VCEL) is a biotech company specializing in cell therapy. Their products are MACI (knee cartilage repair) and Epicel (severe burn treatment). It's a niche medical business. This chart measures momentum. It shows "overheated" (above 70) due to strong data on procedure growth or "oversold" (below 30) due to concerns about reimbursement issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Vericel-Corporation-VCEL&v=1772686550070 "RSI 14 indicator chart for the company's stock Vericel Corporation (VCEL)")
RSI 14 Market Segment - Pharma skin
Vericel (VCEL) is a "regenerative" medicine company. They take *your* cells, grow them, and return them to treat burns (skin) or knee injuries (cartilage). The RSI_14_Seg for their segment (biotech) shows the overall sentiment. It helps us understand: is VCEL's growth due to their unique technology or general hype?
RSI 14 for the overall market
Vericel (VCEL) is a biotech company. Like everything in its sector, it's critically dependent on this chart. Market euphoria is an easy way to raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VCEL (Vericel Corporation)
Vericel is a leader in cell therapies for regenerative medicine. Their MACI products are used to restore cartilage in the knee, and Epicel is used to treat severe burns. This chart shows the average analyst forecast. Their target price reflects the expected rate of adoption of these innovative, but expensive, treatments.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-VCEL-Vericel-Corporation&v=1772686550132 "A chart showing analyst consensus forecasts for the expected stock price. VCEL (Vericel Corporation)")
The difference between the consensus estimate and the actual stock price VCEL (Vericel Corporation)
Vericel is a biotech company specializing in cell therapy for tissue repair. Its products are used to treat burns (Epicel) and cartilage (MACI). This chart shows the gap between the current market valuation and analysts' target price. It highlights the potential experts see in regenerative medicine.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-VCEL-Vericel-Corporation&v=1772686550215 "A chart showing the difference between the consensus forecast and the actual stock price. VCEL (Vericel Corporation)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Vericel is a leader in advanced cell therapy for sports medicine and the treatment of severe burns. The company grows a patient's own cells to restore cartilage or skin. This chart shows general expectations for the regenerative medicine sector, reflecting experts' belief in the commercial success of cell technologies.
Analysts' consensus forecast for the overall market share price
Vericel (VCEL) is a pioneer in regenerative medicine. They take a patient's own cells and grow replacement parts from them: new cartilage for knees (MACI) or new skin for burn victims (Epicel). This chart shows the overall risk appetite in the market, reflecting how willing investors are to invest in breakthrough but complex medical technologies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Vericel Corporation
Vericel is a biotech company specializing in regenerative medicine. They take patient cells and grow them into living tissue for burn treatment (Epicel) and cartilage repair (MACI). This graph is an indicator of their unique niche. It likely reflects the growing number of surgeons using their complex yet effective cell therapies for tissue repair.
AKIMA Market Segment Index - Pharma skin
Vericel (VCEL) is a leader in regenerative medicine, with two unique cell therapy products: MACI (for knee cartilage repair) and Epicel (for burn skin). This summary metric evaluates R&D. The graph shows the segment average. This benchmark: how does this unique technological niche (VCEL) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Vericel is a leader in advanced cell therapy for sports medicine (cartilage) and the treatment of severe burns. This chart, reflecting the market average, provides context. It helps assess how this niche but commercially successful biotech company stacks up against the broader macroeconomic fluctuations affecting healthcare.
